Published in Sci Signal on October 11, 2011
A load driver device for engineering modularity in biological networks. Nat Biotechnol (2014) 1.53
Design principles of regulatory networks: searching for the molecular algorithms of the cell. Mol Cell (2013) 1.34
Nitrogen assimilation in Escherichia coli: putting molecular data into a systems perspective. Microbiol Mol Biol Rev (2013) 1.02
A 'resource allocator' for transcription based on a highly fragmented T7 RNA polymerase. Mol Syst Biol (2014) 1.01
Logic-based models in systems biology: a predictive and parameter-free network analysis method. Integr Biol (Camb) (2012) 0.90
Modular composition of gene transcription networks. PLoS Comput Biol (2014) 0.87
The energy costs of insulators in biochemical networks. Biophys J (2013) 0.82
Tuning genetic clocks employing DNA binding sites. PLoS One (2012) 0.81
How to train your microbe: methods for dynamically characterizing gene networks. Curr Opin Microbiol (2015) 0.81
Comment on "load-induced modulation of signal transduction networks": reconciling ultrasensitivity with bifunctionality? Sci Signal (2012) 0.80
Sensitivity and robustness in covalent modification cycles with a bifunctional converter enzyme. Biophys J (2013) 0.79
Retroactive signaling in short signaling pathways. PLoS One (2012) 0.78
Control theory meets synthetic biology. J R Soc Interface (2016) 0.78
Segregation and crosstalk of D1 receptor-mediated activation of ERK in striatal medium spiny neurons upon acute administration of psychostimulants. PLoS Comput Biol (2014) 0.77
Signaling cascades transmit information downstream and upstream but unlikely simultaneously. BMC Syst Biol (2016) 0.77
Paradoxical results in perturbation-based signaling network reconstruction. Biophys J (2014) 0.76
Synergistic Synthetic Biology: Units in Concert. Front Bioeng Biotechnol (2013) 0.75
Retroactivity in the Context of Modularly Structured Biomolecular Systems. Front Bioeng Biotechnol (2015) 0.75
Loads bias genetic and signaling switches in synthetic and natural systems. PLoS Comput Biol (2014) 0.75
Signaling Architectures that Transmit Unidirectional Information Despite Retroactivity. Biophys J (2017) 0.75
Development of genetic circuitry exhibiting toggle switch or oscillatory behavior in Escherichia coli. Cell (2003) 6.03
Building a cell cycle oscillator: hysteresis and bistability in the activation of Cdc2. Nat Cell Biol (2003) 5.86
BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci U S A (2008) 4.79
Detection of multistability, bifurcations, and hysteresis in a large class of biological positive-feedback systems. Proc Natl Acad Sci U S A (2004) 4.63
Modular cell biology: retroactivity and insulation. Mol Syst Biol (2008) 3.11
BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Res (2006) 2.58
Robustness and fragility of Boolean models for genetic regulatory networks. J Theor Biol (2005) 2.51
Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. J Clin Oncol (2006) 2.49
WISP3 is a novel tumor suppressor gene of inflammatory breast cancer. Oncogene (2002) 2.02
Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt. Breast Cancer Res Treat (2009) 1.98
CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling. Mol Cancer Ther (2007) 1.80
Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am J Pathol (2002) 1.79
Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res (2002) 1.73
Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues. Cancer Res (2006) 1.54
Computational aspects of feedback in neural circuits. PLoS Comput Biol (2006) 1.54
WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer. Breast Cancer Res (2004) 1.51
RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast. Breast Cancer Res Treat (2005) 1.49
Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1. Am J Pathol (2008) 1.48
Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. J Natl Compr Canc Netw (2014) 1.48
Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. Cancer Epidemiol Biomarkers Prev (2002) 1.47
The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells. Neoplasia (2005) 1.42
Escherichia coli PII signal transduction protein controlling nitrogen assimilation acts as a sensor of adenylate energy charge in vitro. Biochemistry (2007) 1.42
Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy. Cancer Res (2005) 1.41
Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer. Clin Cancer Res (2003) 1.40
Urban-rural differences in breast cancer incidence in Egypt (1999-2006). Breast (2010) 1.40
On the number of steady states in a multiple futile cycle. J Math Biol (2007) 1.39
Targeted overexpression of EZH2 in the mammary gland disrupts ductal morphogenesis and causes epithelial hyperplasia. Am J Pathol (2009) 1.35
WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer. Neoplasia (2004) 1.35
Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. Breast Cancer Res Treat (2005) 1.29
Tetrathiomolybdate inhibits angiogenesis and metastasis through suppression of the NFkappaB signaling cascade. Mol Cancer Res (2003) 1.29
Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma. Cancer (2004) 1.26
Shape, size, and robustness: feasible regions in the parameter space of biochemical networks. PLoS Comput Biol (2009) 1.25
RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells. Breast Cancer Res Treat (2004) 1.25
RhoA-GDP regulates RhoB protein stability. Potential involvement of RhoGDIalpha. J Biol Chem (2008) 1.25
Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma. Cancer Res (2006) 1.24
High proportion of inflammatory breast cancer in the Population-based Cancer Registry of Gharbiah, Egypt. Breast J (2009) 1.24
Signaling properties of a covalent modification cycle are altered by a downstream target. Proc Natl Acad Sci U S A (2010) 1.24
Activation of the glnA, glnK, and nac promoters as Escherichia coli undergoes the transition from nitrogen excess growth to nitrogen starvation. J Bacteriol (2002) 1.23
Genetic counseling for BRCA1/2: a randomized controlled trial of two strategies to facilitate the education and counseling process. Am J Med Genet A (2005) 1.21
Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers. Cancer (2010) 1.20
RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res (2006) 1.19
Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor. Mol Cancer Ther (2002) 1.18
Mechanism-independent method for predicting response to multidrug combinations in bacteria. Proc Natl Acad Sci U S A (2012) 1.17
Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer. Cancer Res (2011) 1.16
RhoC expression and head and neck cancer metastasis. Mol Cancer Res (2009) 1.16
p38γ promotes breast cancer cell motility and metastasis through regulation of RhoC GTPase, cytoskeletal architecture, and a novel leading edge behavior. Cancer Res (2011) 1.15
Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells. Mol Cancer Ther (2003) 1.15
Building biological memory by linking positive feedback loops. Proc Natl Acad Sci U S A (2009) 1.12
Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells. Breast Cancer Res (2005) 1.12
Molecular determinants of the inflammatory breast cancer phenotype. Oncology (Williston Park) (2008) 1.12
Breast Cancer Risk Reduction, Version 2.2015. J Natl Compr Canc Netw (2015) 1.12
Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients. Breast (2009) 1.11
Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients. Breast Cancer Res Treat (2007) 1.11
Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy. Breast Cancer Res Treat (2010) 1.10
Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer. Clin Exp Metastasis (2002) 1.10
Global entrainment of transcriptional systems to periodic inputs. PLoS Comput Biol (2010) 1.08
Nanoroughened surfaces for efficient capture of circulating tumor cells without using capture antibodies. ACS Nano (2012) 1.08
Nac-mediated repression of the serA promoter of Escherichia coli. Mol Microbiol (2002) 1.08
A Petri net approach to the study of persistence in chemical reaction networks. Math Biosci (2007) 1.08
Escherichia coli glutamine synthetase adenylyltransferase (ATase, EC 2.7.7.49): kinetic characterization of regulation by PII, PII-UMP, glutamine, and alpha-ketoglutarate. Biochemistry (2007) 1.07
Retroactivity controls the temporal dynamics of gene transcription. ACS Synth Biol (2013) 1.07
Antagonism of PII signalling by the AmtB protein of Escherichia coli. Mol Microbiol (2003) 1.06
RhoC impacts the metastatic potential and abundance of breast cancer stem cells. PLoS One (2012) 1.06
Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1. Mol Cancer (2005) 1.05
Clinical and epidemiologic profile of breast cancer in Tanzania. Breast Dis (2010) 1.05
Crystal structure of the C-terminal domain of the two-component system transmitter protein nitrogen regulator II (NRII; NtrB), regulator of nitrogen assimilation in Escherichia coli. Biochemistry (2004) 1.04
CCN6 (WISP3) as a new regulator of the epithelial phenotype in breast cancer. Cells Tissues Organs (2007) 1.04
Breast cancer characteristics at diagnosis and survival among Arab-American women compared to European- and African-American women. Breast Cancer Res Treat (2008) 1.04
Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma. Mol Cancer Ther (2003) 1.03
Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head and neck cancer. Mol Cancer Ther (2007) 1.03
Multisite phosphorylation provides an effective and flexible mechanism for switch-like protein degradation. PLoS One (2010) 1.02
Rate constants rather than biochemical mechanism determine behaviour of genetic clocks. J R Soc Interface (2008) 1.02
Genetic and biochemical analysis of phosphatase activity of Escherichia coli NRII (NtrB) and its regulation by the PII signal transduction protein. J Bacteriol (2003) 1.02
On the role of cell signaling models in cancer research. Cancer Res (2009) 1.01
Steady-states of receptor-ligand dynamics: a theoretical framework. J Theor Biol (2004) 1.00
Mechanism of the PII-activated phosphatase activity of Escherichia coli NRII (NtrB): how the different domains of NRII collaborate to act as a phosphatase. Biochemistry (2003) 1.00
Physiological role of the GlnK signal transduction protein of Escherichia coli: survival of nitrogen starvation. Mol Microbiol (2002) 0.99
Picosecond-resolution fluorescence lifetime imaging microscopy: a useful tool for sensing molecular interactions in vivo via FRET. Opt Express (2007) 0.99
Control of copper status for cancer therapy. Curr Cancer Drug Targets (2005) 0.99
Quantifying calcium fluxes underlying calcium puffs in Xenopus laevis oocytes. Cell Calcium (2010) 0.98
Minimization of thermodynamic costs in cancer cell invasion. Proc Natl Acad Sci U S A (2013) 0.98
Knowledge gained after a brief CME module on breast cancer diagnosis. J Cancer Educ (2006) 0.97
Geometry and topology of parameter space: investigating measures of robustness in regulatory networks. J Math Biol (2008) 0.97
Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008. Breast Cancer Res Treat (2012) 0.96
Global stability in a chemostat with multiple nutrients. J Math Biol (2006) 0.96
Radiotherapy and antiangiogenic TM in lung cancer. Neoplasia (2002) 0.96
Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007. Cancer Epidemiol Biomarkers Prev (2011) 0.96
Physiological fluorescence lifetime imaging microscopy improves Förster resonance energy transfer detection in living cells. J Biomed Opt (2010) 0.95
Structure-function analysis of glutamine synthetase adenylyltransferase (ATase, EC 2.7.7.49) of Escherichia coli. Biochemistry (2007) 0.95
Genetic determinants of aggressive breast cancer. Annu Rev Med (2008) 0.94
Establishing effective registration systems in resource-limited settings: cancer registration in Kumasi, Ghana. J Registry Manag (2013) 0.94
Trends in Breast Cancer Incidence Rates by Age and Stage at Diagnosis in Gharbiah, Egypt, over 10 Years (1999-2008). J Cancer Epidemiol (2013) 0.94
Mutations altering the N-terminal receiver domain of NRI (NtrC) That prevent dephosphorylation by the NRII-PII complex in Escherichia coli. J Bacteriol (2004) 0.93
Alpha-ketoglutarate controls the ability of the Escherichia coli PII signal transduction protein to regulate the activities of NRII (NrB but does not control the binding of PII to NRII. Biochemistry (2009) 0.93